Eloxx Pharmaceuticals Inc (ELOX) Return on Assets ROA from the first quarter of 2026 to first quarter of 2023 and for the year 2026, Average High and Low, Fundamental Ratios from Mar 31 2026 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Eloxx Pharmaceuticals Inc   (NASDAQ: ELOX)


Eloxx Pharmaceuticals Inc 's ROA from the first quarter of 2026 to the first quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Eloxx Pharmaceuticals Inc 's ROA in the first quarter of 2026?
Eloxx Pharmaceuticals Inc achieved a return on average assets (ROA) of 17.33 % in its first quarter of 2026, this is above ELOX's average return on assets of -120.39%.
Eloxx Pharmaceuticals Inc assets over the 12 months ending in its first quarter of 2026 are valued at $5 million

ROA decreased relative to the period ending Dec 31 2025, due to the decline in net income.

However, within the Healthcare sector 585 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2026 quarter, so far to 3999, from total ROA ranking in the fourth quarter of 2025 at 4985.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Total Assets Change 48.24 % -4.39 % -54.54 % -90.34 % -78.66 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 1 2 -10 -13 -17
Return On Assets (TTM) 17.33 % 41.87 % -247.98 % -252.76 % -175.29 %
ELOX's Total Ranking # 3999 # 4985 # # #
Total Assets (TTM) in million 9 5 3 2 6
Seq. Total Assets Change 61.35 % 77.08 % 45.88 % -64.44 % 4.06 %
Seq. Net Income Change - - - - -

ELOX's 5 Years Annual ROA >> Back to ELOX Management Effectiveness >> Compare ELOX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 81
Sector # 586
Overall # 3960

Return On Assets Statistics
High Average Low
-54.54 %
-120.39 %
-274.9 %
(Mar 31 2026)   (Dec 31 2017)





Financial Statements
Eloxx Pharmaceuticals Inc 's Assets $ 9 million ELOX's Balance sheet
Eloxx Pharmaceuticals Inc 's Income $ -4 million Quarterly ELOX's Income Statement
ELOX's Income by Division See ELOX's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019
Y / Y Total Assets Change -75.05 % -53.2 % 70.48 % -55.06 % 16.15 %
Total Assets in million 5 21 45 26 59
Y / Y Net Income Change - - - - -
Net Income in million -6 -36 -67 -35 -51
Annual Return On Assets -113.76 % -170.74 % -147.83 % -130.59 % -86.36 %

ELOX's 5 Years Annual ROA >> Back to ELOX Management Effectiveness >> Compare ELOX ROA to its Competitors



More Return On Assets Ratios
ELOX's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ELOX's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ELOX's Competitors
Subscribers only: Roa for Eloxx Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for ELOX's Customers

You may also want to know
ELOX's Roi ELOX's Inventory Turnover Ratio ELOX's Growth Rates ELOX's Dividend Comparisons
ELOX's Profitability Ratios ELOX's Asset Turnover Ratio ELOX's Dividend Growth
ELOX's Roe ELOX's Valuation Ratios ELOX's Financial Strength Ratios ELOX's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2026, within Healthcare Sector ROA
Aurinia Pharmaceuticals Inc   47.61 %
Zevra Therapeutics Inc   45.60 %
Earth Science Tech Inc   44.55 %
Tg Therapeutics Inc   42.77 %
Lensar Inc   42.26 %
Sanuwave Health Inc   41.68 %
Dariohealth Corp   37.08 %
Elite Pharmaceuticals Inc   36.39 %
Omeros Corporation  34.53 %
Idexx Laboratories Inc  32.56 %
Innoviva Inc   32.36 %
Agenus Inc  30.03 %
Abeona Therapeutics Inc   29.55 %
Escalon Medical Corp   29.20 %
Protagenic Therapeutics Inc new  27.96 %
Adma Biologics Inc   27.37 %
Acadia Pharmaceuticals Inc   26.24 %
Ironwood Pharmaceuticals inc   26.02 %
Theravance Biopharma inc   25.46 %
Spero Therapeutics Inc   24.95 %
Medpace Holdings Inc   24.79 %
Mettler toledo International Inc   24.47 %
Qhslab Inc   23.09 %
Eli Lilly And Company  22.73 %
Incyte Corporation  21.65 %
Iradimed Corporation  21.25 %
Catalyst Pharmaceuticals Inc   20.71 %
Engene Therapeutics Inc   20.52 %
Vaxart Inc   20.07 %
Indivior Pharmaceuticals Inc   19.14 %

Date modified: 2026-10-05T11:03:40+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.